NFL Biosciences is selling at 1.86 as of the 7th of February 2025; that is 1.59 percent down since the beginning of the trading day. The stock's last reported lowest price was 1.8. NFL Biosciences has hardly any chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 9th of November 2024 and ending today, the 7th of February 2025. Click here to learn more.
Although NFL Biosciences' alpha and beta are two of the key measurements used to evaluate NFL Biosciences' performance over the market, the standard measures of volatility play an important role as well.
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NFL Biosciences stock to make a market-neutral strategy. Peer analysis of NFL Biosciences could also be used in its relative valuation, which is a method of valuing NFL Biosciences by comparing valuation metrics with similar companies.
When running NFL Biosciences' price analysis, check to measure NFL Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NFL Biosciences is operating at the current time. Most of NFL Biosciences' value examination focuses on studying past and present price action to predict the probability of NFL Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NFL Biosciences' price. Additionally, you may evaluate how the addition of NFL Biosciences to your portfolios can decrease your overall portfolio volatility.